Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$58.39 - $296.54 $2.51 Million - $12.7 Million
42,971 New
42,971 $12.5 Million
Q3 2022

Nov 14, 2022

BUY
$60.57 - $79.51 $254,878 - $334,578
4,208 Added 11.53%
40,702 $2.65 Million
Q2 2022

Aug 15, 2022

BUY
$58.04 - $100.2 $21,300 - $36,773
367 Added 1.02%
36,494 $2.61 Million
Q1 2022

May 11, 2022

BUY
$55.89 - $101.89 $77,295 - $140,913
1,383 Added 3.98%
36,127 $3.55 Million
Q4 2021

Feb 11, 2022

SELL
$72.34 - $95.09 $720,000 - $946,430
-9,953 Reduced 22.27%
34,744 $2.95 Million
Q3 2021

Nov 12, 2021

BUY
$78.35 - $105.02 $382,896 - $513,232
4,887 Added 12.28%
44,697 $3.57 Million
Q2 2021

Aug 11, 2021

BUY
$97.2 - $137.59 $484,347 - $685,610
4,983 Added 14.31%
39,810 $3.88 Million
Q1 2021

May 13, 2021

SELL
$108.54 - $125.2 $73,698 - $85,010
-679 Reduced 1.91%
34,827 $4.07 Million
Q4 2020

Feb 09, 2021

SELL
$110.06 - $133.7 $78,582 - $95,461
-714 Reduced 1.97%
35,506 $3.95 Million
Q3 2020

Nov 12, 2020

SELL
$99.78 - $124.21 $82,418 - $102,597
-826 Reduced 2.23%
36,220 $4.3 Million
Q2 2020

Aug 12, 2020

BUY
$60.13 - $125.71 $71,133 - $148,714
1,183 Added 3.3%
37,046 $4.2 Million
Q1 2020

May 06, 2020

BUY
$66.76 - $93.49 $112,757 - $157,904
1,689 Added 4.94%
35,863 $2.39 Million
Q4 2019

Feb 14, 2020

BUY
$84.28 - $118.5 $141,506 - $198,961
1,679 Added 5.17%
34,174 $3.11 Million
Q3 2019

Nov 07, 2019

BUY
$84.4 - $106.53 $30,215 - $38,137
358 Added 1.11%
32,495 $2.8 Million
Q2 2019

Aug 12, 2019

BUY
$91.13 - $142.5 $123,481 - $193,087
1,355 Added 4.4%
32,137 $3.37 Million
Q1 2019

May 14, 2019

SELL
$103.48 - $143.84 $3,414 - $4,746
-33 Reduced 0.11%
30,782 $3.86 Million
Q4 2018

Feb 11, 2019

SELL
$94.77 - $215.54 $632,115 - $1.44 Million
-6,670 Reduced 17.79%
30,815 $3.47 Million
Q3 2018

Nov 09, 2018

BUY
$207.3 - $300.31 $611,535 - $885,914
2,950 Added 8.54%
37,485 $0
Q2 2018

Aug 06, 2018

BUY
$101.55 - $313.9 $343,949 - $1.06 Million
3,387 Added 10.87%
34,535 $9.66 Million
Q1 2018

May 15, 2018

BUY
$93.35 - $149.04 $25,204 - $40,240
270 Added 0.87%
31,148 $3.64 Million
Q4 2017

Feb 09, 2018

BUY
$39.35 - $97.37 $1.22 Million - $3.01 Million
30,878
30,878 $2.83 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $3.71B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.